Plasma Citrulline in Preterm With NEC

Completed

• Conditions: NEC; Citrulline

• Registration Number: NCT04313933
• Lead Sponsor: Ain Shams University

Brief Summary

Aim of study

Detailed Description

Introduction

Study Timeline

• Study Start: 2019-03-12
• Status Verified: 2020-02
• Primary Completion: 2020-02-10
• Study Completion: 2020-02-15
• Study First Submitted: 2020-03-14
• Study First Submitted QC: 2020-03-17
• Last Update Submitted: 2020-03-17
• Study First Posted: 2020-03-18
• Last Update Posted: 2020-03-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• preterm neonates < 35 weeks Preterm neonates< 2kg Preterm neonates diagnosed with necrotizing enterocolitis

Read More

Exclusion Criteria

• renal dysfunction Inborn error of metabolism Congenital malformation

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
plasma citrulline as a marker of Necrotizing enterocolitis diagnosis	1 Year	Compare plasma citrulline in NEC and comparing it with properly matched healthy neonates

Secondary Outcome Measures

Name	Time	Method
Citrulline as a marker of intestinal recovery	1 year	Follow up plasma citrulline level after initiation of feeding

Trial Locations

Locations (1)

AinShams University; 🇪🇬 Cairo, Egypt